Figure 1
Changes of liver stiffness values and CD19+ cell levels at baseline and at three months after the end of treatment in a singol patient. Liver stiffness values (17.6 kPa before treatment vs 13.3 at month 3 after treatment) (panel A) and CD19+ levels (110 × 106 L before treatment vs 0 × 106 L at month 3 after treatment) (panel B).